Skip to main content
PolG, Primary Mitochondrial MyopathyRare diseaseGeneticsChildren's healthBrain and nerves

What this study is

The PIONEER study is a prospective, natural history study dedicated to characterizing the clinical progression of POLG-related disorders. The research aims to bridge the gap between genetic diagnosis and drug development by mapping how these rare mitochondrial conditions evolve over time. By observing the disease's natural trajectory through a multi-center approach, The study identifies critical clinical milestones that serve as a foundation for evaluating therapeutic efficacy and future therapeutic interventions

Study details

Official title
Global Prospective Natural History Study of POLG Disease
Sponsor
The POLG Foundation
Conditions
PolG, Primary Mitochondrial Myopathy
Enrolling
300 people
Starts
2026-06-17
Est. completion
2031-06-17
Record
View on ClinicalTrials.gov ↗